Decrease of β-amyloid peptide precursor and ceruloplasmin mRNA levels in patients with Alzheimer’s disease support impairment of cellular iron efflux in this pathology

This research was supported by the Fundação para a Ciência e a Tecnologia (FCT) [SFRH/BPD/29354/2006 to MM, SFRH/BD/60718/2009 to BS, and SFRH/BD/48671/2008 to LM]; Fundação Astrazeneca (Research Grant awarded through the “Programme of Support to Research”); Instituto Nacional de Saúde Dr. Ricardo J...

Full description

Bibliographic Details
Main Author: Silva, Bruno (author)
Other Authors: Guerreiro, Cláudia (author), C. Crespo, Ângela (author), Marques, Liliana (author), Marcelino, Erica (author), Maruta, Carolina (author), Costa, Sónia (author), Timóteo, Ângela (author), Vilares, Arminda (author), Simões Couto, Frederico (author), Faustino, Paula (author), Verdelho, Ana (author), Guerreiro, Manuela (author), Herrero, Ana (author), Costa, Cristina (author), de Mendonça, Alexandre (author), Martins, Madalena (author), Costa, Luciana (author)
Format: conferenceObject
Language:eng
Published: 2015
Subjects:
Determinantes Imunológicos em Doenças Crónicas
Alzheimer’s disease
Iron Metabolism
Online Access:http://hdl.handle.net/10400.18/2886
Country:Portugal
Oai:oai:repositorio.insa.pt:10400.18/2886
Description
Summary:This research was supported by the Fundação para a Ciência e a Tecnologia (FCT) [SFRH/BPD/29354/2006 to MM, SFRH/BD/60718/2009 to BS, and SFRH/BD/48671/2008 to LM]; Fundação Astrazeneca (Research Grant awarded through the “Programme of Support to Research”); Instituto Nacional de Saúde Dr. Ricardo Jorge; Portuguese Ministry of Health (Research Grant 53/2007 of the “Comissão de Fomento da Investigação em Cuidados de Saúde”); Lundbeck Portugal, Lda (Research Grant).

Similar Items